Initial Statement of Beneficial Ownership of Securities

Kenneth Howard Warrington, Jr. reported beneficial ownership of BioStem Technologies, Inc. common stock. He directly owns 27,140 shares of common stock. Additionally, he holds a vested stock option to buy 7,462 shares of common stock with an exercise price of $1.80, expiring on March 29, 2032. He also holds 8,467 restricted stock units (RSUs) vesting quarterly by September 15, 2024, and 5,094 RSUs vesting quarterly by August 27, 2025. Each RSU represents a contingent right to one share of common stock. The reporting owner is a director of the company.